{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:27:19Z","timestamp":1780626439184,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003024","name":"Shanghai Education Development Foundation","doi-asserted-by":"publisher","award":["14SG28"],"award-info":[{"award-number":["14SG28"]}],"id":[{"id":"10.13039\/501100003024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21372001"],"award-info":[{"award-number":["21372001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21672064"],"award-info":[{"award-number":["21672064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.bmc.2017.10.017","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T22:18:41Z","timestamp":1508192321000},"page":"6467-6478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely"],"prefix":"10.1016","volume":"25","author":[{"given":"Wenhua","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2017.10.017_b0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/71816","article-title":"Malaria","volume":"18","author":"Persidis","year":"2000","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.bmc.2017.10.017_b0010","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1021\/jm501439w","article-title":"Synthesis of gallinamide analogues as potent falcipain inhibitors and antimalarials","volume":"57","author":"Conroy","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0015","doi-asserted-by":"crossref","first-page":"e718","DOI":"10.1371\/journal.pntd.0000718","article-title":"\u201cManifesto\u201d for advancing the control and elimination of neglected tropical diseases","volume":"4","author":"Hotez","year":"2010","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.bmc.2017.10.017_b0020","unstructured":"World Malaria Report 2016; World Health Organization: Geneva. http:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2016\/en\/, 2016."},{"key":"10.1016\/j.bmc.2017.10.017_b0025","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1021\/acs.jmedchem.7b00621","article-title":"Benzoxaborole antimalarial agents. Part 5. Lead optimization of novel amide pyrazinyloxy benzoxaboroles and identification of a preclinical candidate","volume":"60","author":"Zhang","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0030","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","article-title":"Malaria","volume":"383","author":"White","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2017.10.017_b0035","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1021\/acs.jmedchem.6b01641","article-title":"Antimalarial pyrido[1,2-a]benzimidazoles: Lead optimization, parasite life cycle stage profile, mechanistic evaluation, killing kinetics, and in vivo oral efficacy in a mouse model","volume":"60","author":"Singh","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0040","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrmicro.2016.79","article-title":"Plasmodium species: master renovators of their host cells","volume":"14","author":"de Koning-Ward","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2017.10.017_b0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4269\/ajtmh.2001.64.97","article-title":"The neglected burden of Plasmodium vivax malaria","volume":"64","author":"Mendis","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.bmc.2017.10.017_b0050","doi-asserted-by":"crossref","first-page":"e2012061","DOI":"10.4084\/mjhid.2012.061","article-title":"Pathogenesis of malaria in tissues and blood","volume":"4","author":"Autino","year":"2012","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.bmc.2017.10.017_b0055","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nri3742","article-title":"Innate sensing of malaria parasites","volume":"14","author":"Gazzinelli","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bmc.2017.10.017_b0060","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1021\/acs.jmedchem.6b01685","article-title":"Accepting the invitation to open innovation in malaria drug discovery: Synthesis, biological evaluation, and investigation on the structure-activity relationships of benzo[b]thiophene-2-carboxamides as antimalarial agents","volume":"60","author":"Pieroni","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0065","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/j.micinf.2006.07.011","article-title":"Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations","volume":"8","author":"Musset","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1016\/j.bmc.2017.10.017_b0070","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2017.10.017_b0075","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2331","article-title":"Artemisinin resistance: current status and scenarios for containment","volume":"8","author":"Dondorp","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2017.10.017_b0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2017.10.017_b0085","doi-asserted-by":"crossref","first-page":"8614","DOI":"10.1038\/ncomms9614","article-title":"Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa","volume":"6","author":"St. Laurent","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2017.10.017_b0090","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1021\/acs.jmedchem.6b01733","article-title":"Target elucidation by cocrystal structures of NADH-ubiquinone oxidoreductase of Plasmodium falciparum (PfNDH2) with small molecule to eliminate drug-resistant malaria","volume":"60","author":"Yang","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"Andrews","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.bmc.2017.10.017_b0100","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1021\/acs.jmedchem.6b01673","article-title":"Optimization of 2-anilino 4-amino substituted quinazolines into potent antimalarial agents with oral in vivo activity","volume":"60","author":"Gilson","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0105","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1021\/acsinfecdis.5b00049","article-title":"Next-generation sequencing ofPlasmodium vivaxpatient samples shows evidence of direct evolution in drug-resistance genes","volume":"1","author":"Flannery","year":"2015","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2017.10.017_b0110","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1016\/j.bmc.2017.08.049","article-title":"A novel class of Plasmodial ClpP protease inhibitors as potential antimalarial agents","volume":"25","author":"Sourabh","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0115","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1016\/j.bmc.2017.05.048","article-title":"Synthesis and evaluation of symmetric acyclic nucleoside bisphosphonates as inhibitors of the Plasmodium falciparum, Plasmodium vivax and human 6-oxopurine phosphoribosyltransferases and the antimalarial activity of their prodrugs","volume":"25","author":"Petr","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0120","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.bmc.2017.05.054","article-title":"1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities","volume":"25","author":"Sampark","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0125","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1016\/j.bmc.2015.02.050","article-title":"Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents","volume":"23","author":"Marvin","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0130","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/415673a","article-title":"The pathogenic basis of malaria","volume":"415","author":"Miller","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2017.10.017_b0135","doi-asserted-by":"crossref","first-page":"35236","DOI":"10.1074\/jbc.M404235200","article-title":"Selection of cysteine protease inhibitor-resistant malaria parasites is accompanied by amplification of falcipain genes and alteration in inhibitor transport","volume":"279","author":"Singh","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0140","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1021\/bi500060h","article-title":"Quantum mechanics\/molecular mechanics studies of the mechanism offalcipain-2 inhibition by the epoxysuccinate E64","volume":"53","author":"Arafet","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2017.10.017_b0145","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.chembiol.2012.09.020","article-title":"The antimalarial natural product symplostatin 4 is a nanomolar inhibitor of the food vacuole falcipains","volume":"19","author":"Stolze","year":"2012","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmc.2017.10.017_b0150","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1080\/07391102.2015.1108231","article-title":"Analysis of non-peptidic compounds as potential malarial inhibitors against Plasmodium cysteine proteases via integrated virtual screening workflow","volume":"35","author":"Musyoka","year":"2016","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2017.10.017_b0155","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1073\/pnas.0307720101","article-title":"Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum","volume":"101","author":"Sijwali","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2017.10.017_b0160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.molbiopara.2006.06.013","article-title":"Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum","volume":"150","author":"Sijwali","year":"2006","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmc.2017.10.017_b0165","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1016\/j.bmcl.2008.05.068","article-title":"Design and synthesis of novel 2-pyridone peptidomimetic falcipain 2\/3 inhibitors","volume":"18","author":"Verissimo","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.10.017_b0170","doi-asserted-by":"crossref","first-page":"25697","DOI":"10.1074\/jbc.M109.014340","article-title":"Vinyl sulfones as antiparasitic agents and a structural basis for drug design","volume":"284","author":"Kerr","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0175","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1021\/jm100556b","article-title":"Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series","volume":"53","author":"Coteron","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0180","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/jm900946n","article-title":"Michael acceptor based antiplasmodial and antitrypanosomal cysteine protease inhibitors with unusual amino acids","volume":"53","author":"Breuning","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0185","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/ci200029y","article-title":"Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library","volume":"51","author":"Shah","year":"2011","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2017.10.017_b0190","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/ci2005516","article-title":"Computer-aided drug design of falcipain inhibitors: virtual screening, structure-activity relationships, hydration site thermodynamics, and reactivity analysis","volume":"52","author":"Shah","year":"2012","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2017.10.017_b0195","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/med.20163","article-title":"Falcipain-2 inhibitors","volume":"30","author":"Ettari","year":"2010","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2017.10.017_b0200","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1021\/jm501439w","article-title":"Synthesis of gallinamide A analogues as potentfalcipaininhibitors and antimalarials","volume":"57","author":"Conroy","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0205","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2174\/156802612799362913","article-title":"Falcipain inhibition as a promising antimalarial target","volume":"12","author":"Marco","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0210","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.bmc.2015.02.062","article-title":"Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents","volume":"23","author":"Sai","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0215","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.bmc.2015.02.029","article-title":"Design, synthesis and biological evaluation of functionalized phthalimides: A new class of antimalarials and inhibitors of falcipain-2, a major hemoglobinase of malaria parasite","volume":"23","author":"Anil","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0220","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/1475-2875-13-402","article-title":"Genetic mutations in Plasmodium falciparum and Plasmodium vivax dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) in Vanuatu and Solomon islands prior to the introduction of artemisinin combination therapy","volume":"13","author":"Gresty","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.bmc.2017.10.017_b0225","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.bpj.2014.09.039","article-title":"Electrostatic channeling in P. falciparum DHFR-TS: brownian dynamics and smoluchowski modeling","volume":"107","author":"Metzger","year":"2014","journal-title":"Biophys J"},{"key":"10.1016\/j.bmc.2017.10.017_b0230","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.1021\/cr500543f","article-title":"Antimalarials in development in 2014","volume":"114","author":"Barnett","year":"2014","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2017.10.017_b0235","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.1021\/bi400852h","article-title":"Elucidating features that drive the design of selective antifolates using crystal structures of human dihydrofolate reductase","volume":"52","author":"Lamb","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2017.10.017_b0240","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.bmcl.2011.12.011","article-title":"Design and synthesis of small molecular dual inhibitor of falcipain-2 and dihydrofolate reductase as antimalarial agent","volume":"22","author":"Huang","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.10.017_b0245","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1128\/AAC.00308-09","article-title":"In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation","volume":"53","author":"Kiara","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2017.10.017_b0250","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1128\/AAC.01526-09","article-title":"Preclinical evaluation of the antifolate QN254, 5-chloro-N\u20326\u2032-(2,5-dimethoxy-benzyl)-aui- nazoline-2,4,6-triamine, as an antimalarial drug candidate","volume":"54","author":"Nzila","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2017.10.017_b0255","doi-asserted-by":"crossref","first-page":"16823","DOI":"10.1073\/pnas.1204556109","article-title":"Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target","volume":"109","author":"Yuthavong","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2017.10.017_b0260","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1021\/jm0009181","article-title":"Development of a lead inhibitor for the A16V+S108T mutant of dihydrofolate reductase from the cycloguanil-resistant strain (T9\/94) of Plasmodium falciparum","volume":"43","author":"Yuthavong","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.10.017_b0265","doi-asserted-by":"crossref","first-page":"16708","DOI":"10.1073\/pnas.1205414109","article-title":"Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum","volume":"109","author":"Malmquist","year":"2012","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089617316073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089617316073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:52:45Z","timestamp":1760835165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089617316073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":53,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0968089617316073"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2017.10.017","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2017.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}